These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 8149978

  • 1. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A, Nieoullon A, Amalric M.
    Eur J Pharmacol; 1994 Jan 14; 251(2-3):229-36. PubMed ID: 8149978
    [Abstract] [Full Text] [Related]

  • 2. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
    Ouagazzal A, Amalric M.
    Eur J Pharmacol; 1995 Dec 27; 294(1):137-46. PubMed ID: 8788425
    [Abstract] [Full Text] [Related]

  • 3. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP, Rogawski MA.
    Behav Brain Res; 1995 Oct 27; 70(2):145-51. PubMed ID: 8561905
    [Abstract] [Full Text] [Related]

  • 4. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E, Mele A, Oliverio A, Pert A.
    Neuroscience; 2001 Oct 27; 104(1):105-16. PubMed ID: 11311535
    [Abstract] [Full Text] [Related]

  • 5. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A, Castellano C, Felici A, Cabib S, Caccia S, Oliverio A.
    Eur J Pharmacol; 1996 Jul 11; 308(1):1-12. PubMed ID: 8836626
    [Abstract] [Full Text] [Related]

  • 6. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N, Flumerfelt BA, Rajakumar N.
    Neuroscience; 2001 Jul 11; 102(2):391-9. PubMed ID: 11166125
    [Abstract] [Full Text] [Related]

  • 7. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
    Mele A, Thomas DN, Pert A.
    Neuroscience; 1998 Jan 11; 82(1):43-58. PubMed ID: 9483502
    [Abstract] [Full Text] [Related]

  • 8. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J, Rajakumar N.
    Neuroscience; 2003 Jan 11; 122(3):739-45. PubMed ID: 14622917
    [Abstract] [Full Text] [Related]

  • 9. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S, Ozer H, Starr M.
    Eur J Pharmacol; 1997 Aug 06; 332(2):153-60. PubMed ID: 9286616
    [Abstract] [Full Text] [Related]

  • 10. Functional interactions between glutamate and dopamine in the rat striatum.
    Amalric M, Ouagazzal A, Baunez C, Nieoullon A.
    Neurochem Int; 1994 Aug 06; 25(2):123-31. PubMed ID: 7994193
    [Abstract] [Full Text] [Related]

  • 11. Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine.
    St-Pierre JA, Bédard PJ.
    Eur J Pharmacol; 1995 Jan 16; 272(2-3):123-9. PubMed ID: 7713155
    [Abstract] [Full Text] [Related]

  • 12. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH.
    Eur J Pharmacol; 1996 Aug 01; 309(1):1-11. PubMed ID: 8864686
    [Abstract] [Full Text] [Related]

  • 13. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM, Kreipke CW, Walker PD.
    Neuroscience; 2006 Aug 01; 137(2):505-17. PubMed ID: 16289829
    [Abstract] [Full Text] [Related]

  • 14. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S, Krentz L, Moore C, Meshul CK.
    Synapse; 2001 Oct 01; 42(1):54-61. PubMed ID: 11668591
    [Abstract] [Full Text] [Related]

  • 15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 01; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 16. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K, Czyrak A, Maćkowiak M, Fijał K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 01; 353(5):517-27. PubMed ID: 8740145
    [Abstract] [Full Text] [Related]

  • 17. A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine: involvement of NMDA receptors.
    Pacchioni AM, Gioino G, Assis A, Cancela LM.
    Ann N Y Acad Sci; 2002 Jun 01; 965():233-46. PubMed ID: 12105099
    [Abstract] [Full Text] [Related]

  • 18. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.
    Svensson A, Carlsson ML, Carlsson A.
    J Neural Transm Gen Sect; 1995 Jun 01; 101(1-3):127-48. PubMed ID: 8695043
    [Abstract] [Full Text] [Related]

  • 19. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 20. Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model.
    St-Pierre JA, Bédard PJ.
    Brain Res; 1994 Oct 17; 660(2):255-60. PubMed ID: 7820694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.